NOTE 9 – SHARE-BASED COMPENSATION

The Company has a share-based compensation plan ("Plan"), under which options, restricted stock, restricted stock units, stock appreciation rights, performance stock, performance units, and other awards based on, or related to, shares of the Company's common stock may be granted from shares authorized but unissued or shares previously issued and reacquired by the Company. The maximum number of shares of common stock approved by the Company’s shareholders to be issued under the Plan was increased from six million to nine million shares during fiscal 2014. Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of the Company or its subsidiaries. In the event of a change in control (as defined in the Plan), the vesting of awards may be accelerated. The Plan, aspects of which are more fully described below, prohibits further awards from being issued under prior plans. The Company incurred total share-based compensation expenses of $3.7 million, $4.1 million and $4.0 million in fiscal years 2015, 2014 and 2013, respectively. No share-based compensation cost was capitalized as part of an asset and no related income tax benefits were recorded during the fiscal years presented.

Stock Options

Option awards generally vest in one to four years, and have a ten year contractual term. All incentive and non-qualified stock option grants must have an exercise price no less than the market value of the underlying common stock on the date of grant. The grant date fair values of options are based on the closing prices of the Company’s common stock on the date of grant using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of the Company's stock. The Company uses historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that the options granted are expected to remain outstanding. The risk-free rate of return for the estimated term of the option is based on the U.S. Treasury yield curve in effect at the date of grant.

The weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair values of options issued during fiscal years 2015, 2014 and 2013 are presented in the following table:

	Year Ended
	November 1, 2015			November 2, 2014			November 3, 2013

Expected volatility		53.7	%		61.0	%		98.0	%

Risk-free rate of return		1.3 – 1.6	%		1.4	%		0.5 – 1.4	%

Dividend yield		0.0	%		0.0	%		0.0	%

Expected term	4.7 years			4.6 years			4.3 years

A summary of option activity under the Plan as of November 1, 2015, and changes during the year then ended is presented as follows:

Options	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life	Aggregate Intrinsic Value

Outstanding at November 2, 2014		4,076,781		$	7.60
Granted		679,800			8.32
Exercised		(459,188	)		4.60
Cancelled and forfeited		(494,225	)		13.82
Outstanding at November 1, 2015		3,803,168		$	7.29	6.0 years	$	11,215
Exercisable at November 1, 2015		2,299,693		$	6.92	4.5 years	$	8,592
Vested and expected to vest as of November 1, 2015		3,705,186		$	7.28	5.9 years	$	11,039

The weighted-average grant date fair value of options granted during fiscal years 2015, 2014 and 2013 were $3.81, $4.44 and $4.00, respectively. The total intrinsic value of options exercised during fiscal years 2015, 2014 and 2013 was $2.0 million, $1.4 million and $1.6 million, respectively.

The Company received cash from option exercises of $2.2 million, $1.1 million and $0.5 million in fiscal years 2015, 2014 and 2013, respectively. As of November 1, 2015, the total unrecognized compensation cost of unvested option awards was approximately $3.9 million. That cost is expected to be recognized over a weighted-average amortization period of 2.4 years.

Restricted Stock

The Company periodically grants restricted stock awards. The restrictions on these awards typically lapse over a service period of one to four years. The weighted-average grant date fair values of restricted stock awards issued during fiscal years 2015, 2014 and 2013 were $8.28, $8.86 and $5.48, respectively. The total fair value of awards for which restrictions lapsed was $1.4 million, $1.5 million and $1.3 million during fiscal years 2015, 2014 and 2013, respectively. As of November 1, 2015, the total compensation cost for restricted stock awards not yet recognized was approximately $0.8 million. That cost is expected to be recognized over a weighted-average amortization period of 2.2 years.

A summary of the status of the Company's outstanding restricted stock awards as of November 1, 2015, is presented below:

Restricted Stock	Shares			Weighted-Average Fair Value at Grant Date

Outstanding at November 2, 2014		235,481		$	6.81
Granted		121,334			8.28
Vested		(159,039	)		7.25
Cancelled		(8,188	)		7.87
Outstanding at November 1, 2015		189,588		$	7.34
Vested and expected to vest as of November 1, 2015		179,471		$	7.35

Employee Stock Purchase Plan

The Company's Employee Stock Purchase Plan ("ESPP") permits employees to purchase shares at 85% of the lower of the closing market price at the commencement or ending date of the Plan year (approximately one year). The Company recognizes the ESPP expense during that same period. As of November 1, 2015, the maximum number of shares of common stock approved by the Company's shareholders to be purchased under the ESPP was 1.5 million shares. Under the ESPP, approximately 1.3 million shares had been issued through November 1, 2015, and approximately 50,000 shares are subject to outstanding subscriptions. As of November 1, 2015, the total compensation cost related to the ESPP not yet recognized was $0.1 million, which is expected to be recognized in fiscal 2016.